Related Experiment Video
Updated: Oct 21, 2025
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients
Juan Francisco Gutiérrez-Bautista1, Antonio Rodriguez-Nicolas2, Antonio Rosales-Castillo3
1Servicio de Análisis Clínicos e Inmunología, Hospital Universitario Virgen de Las Nieves, Granada, Spain; Programa de Doctorado en Biomedicina, University of Granada, Spain.
Background:
Human leukocyte antigen (HLA) plays an important role in immune responses to infections, especially in the development of acquired immunity. Given the high degree of polymorphisms that HLA molecules present, some will be more or less effective in controlling SARS-CoV-2 infection. We wanted to analyze whether certain polymorphisms may be involved in the protection or susceptibility to COVID-19.
Methods:
We studied the polymorphisms in HLA class I (HLA-A, -B and -C) and II (HLA-DRB1 and HLA-DQB1) molecules in 450 patients who required hospitalization for COVID-19, creating one of the largest HLA-typed patient cohort to date.
Results:
Our results show that there is no relationship between HLA polymorphisms or haplotypes and susceptibility or protection to COVID-19.
Conclusion:
Our results may contribute to resolve the contradictory data on the role of HLA polymorphisms in COVID-19 infection.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
01:11Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...